DSDharmesh Singh

Dharmesh Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dharmesh Singh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic Efficacy and Correlation of Intravoxel Incoherent Motion (IVIM) and Contrast‐Enhanced (CE) MRI Perfusion Parameters in Oncology Imaging: A Systematic Review and Meta‐Analysis

    by Abhijith S., Rajagopal Kadavigere, Priya P. S., Dharmesh Singh, Priyanka, Tancia Pires, Dileep Kumar, Saikiran Pendem

    Background: Intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) is a noncontrast technique estimating diffusion and perfusion parameters via multiple b ‐values, essential for oncology imaging. However, there is limited collective evidence regarding the efficacy of IVIM in oncology imaging compared to contrast‐enhanced (CE) MRI perfusion techniques. This systematic review and meta‐analysis compared IVIM′s diagnostic accuracy and correlation with CE MRI perfusion techniques. Methods: Following PRISMA guidelines (PROSPERO‐registered), a literature search across five databases (PubMed, Scopus, Embase, Web of Science, and Cochrane Library) was conducted. Diagnostic metrics, including AUC, sensitivity, specificity, and correlation coefficients, were analyzed using a random‐effects model, with heterogeneity and publication bias assessed via I 2 statistics and Egger′s test. Results: Eighteen studies on breast, rectal, and brain cancers were analyzed. For breast cancer, IVIM showed 83.50% sensitivity and 81.24% specificity compared to dynamic contrast‐enhanced (DCE) MRI′s 88.04% sensitivity and 65.98% specificity. In rectal cancer, IVIM achieved 70.9% sensitivity and 56.2% specificity, outperforming DCE MRI′s 58.11% sensitivity and 72.49% specificity. For gliomas, IVIM demonstrated 92.27% sensitivity and 74.06% specificity compared to dynamic susceptibility contrast (DSC) MRI′s 95.71% sensitivity and 92.91% specificity. Correlations between IVIM and CE parameters were weak to moderate. Conclusion: IVIM demonstrated equal or superior diagnostic performance to CE MRI in breast cancer, rectal cancer, and gliomas, offering a noncontrast alternative. However, unclear parameter correlations warrant future studies focusing on IVIM protocol optimization based on perfusion regimes.